Article ; Online: KEYNOTE - D36: personalized immunotherapy with a neoepitope vaccine, EVX-01 and pembrolizumab in advanced melanoma.
Future oncology (London, England)
2022 Volume 18, Issue 31, Page(s) 3473–3480
Abstract: Despite improvements made with checkpoint inhibitor (CPI) therapy, a need for new approaches to improve outcomes for patients with unresectable or metastatic melanoma remains. EVX-01, a personalized neoepitope vaccine, combined with pembrolizumab ... ...
Abstract | Despite improvements made with checkpoint inhibitor (CPI) therapy, a need for new approaches to improve outcomes for patients with unresectable or metastatic melanoma remains. EVX-01, a personalized neoepitope vaccine, combined with pembrolizumab treatment, holds the potential to fulfill this need. Here we present the rationale and novel design behind the KEYNOTE - D36 trial: an open label, single arm, phase II trial aiming to establish the clinical proof of concept and evaluate the safety of EVX-01 in combination with pembrolizumab in CPI naive patients with unresectable or metastatic melanoma. The primary objective is to evaluate if EVX-01 improves best overall response after initial stable disease or partial response to pembrolizumab treatment, in patients with advanced melanoma. The novel end points ensure a decisive readout which may prove helpful before making major investments in phase III trials with limited phase I data. |
---|---|
MeSH term(s) | Humans ; Melanoma/drug therapy ; Antibodies, Monoclonal, Humanized/therapeutic use ; Immunotherapy ; Vaccines/therapeutic use |
Chemical Substances | pembrolizumab (DPT0O3T46P) ; Antibodies, Monoclonal, Humanized ; Vaccines |
Language | English |
Publishing date | 2022-09-01 |
Publishing country | England |
Document type | Journal Article ; Clinical Trial Protocol |
ZDB-ID | 2274956-1 |
ISSN | 1744-8301 ; 1479-6694 |
ISSN (online) | 1744-8301 |
ISSN | 1479-6694 |
DOI | 10.2217/fon-2022-0694 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 6478: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.